Your browser doesn't support javascript.
loading
Biomarker guidance in selection among breakthrough treatment options in advanced and recurrent endometrial cancer.
Chan, John K; Tewari, Krishnansu; Monk, Bradley J; Herzog, Thomas J; Coleman, Robert L; Richardson, Michael T; Kapp, Daniel S; Francoeur, Alex A.
Afiliación
  • Chan JK; California Pacific / Palo Alto Medical Foundation, Sutter Health, San Francisco, CA, United States of America. Electronic address: john.chan@sutterhealth.org.
  • Tewari K; University of California Irvine, Orange, CA, United States of America.
  • Monk BJ; Florida Cancer Specialists and Research Institute, West Palm Beach, FL 33401, United States of America.
  • Herzog TJ; University of Cincinnati Cancer Center, University of Cincinnati, Cincinnati, OH, United States of America.
  • Coleman RL; Texas Oncology, Shenandoah, TX, United States of America.
  • Richardson MT; University of California Los Angeles, Los Angeles, CA, United States of America.
  • Kapp DS; Stanford University, Stanford, CA, United States of America.
  • Francoeur AA; University of California Irvine, Orange, CA, United States of America.
Gynecol Oncol ; 187: 249-252, 2024 08.
Article en En | MEDLINE | ID: mdl-38838439
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Biomarcadores de Tumor / Neoplasias Endometriales / Recurrencia Local de Neoplasia Límite: Female / Humans Idioma: En Revista: Gynecol Oncol / Gynecol. oncol / Gynecologic oncology Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Biomarcadores de Tumor / Neoplasias Endometriales / Recurrencia Local de Neoplasia Límite: Female / Humans Idioma: En Revista: Gynecol Oncol / Gynecol. oncol / Gynecologic oncology Año: 2024 Tipo del documento: Article